Che Xiao-Ru, Wang Yong-Jie, Zheng Hai-Yan
Department of Cardiology, Zhejiang Province People's Hospital, Hangzhou, China.
Department of Cardiology, People's Hospital of Hangzhou Medical College, Hangzhou, China.
World J Emerg Med. 2020;11(3):169-173. doi: 10.5847/wjem.j.1920-8642.2020.03.007.
The incidence of hypertensive intracerebral hemorrhage (HICH) has been increasing during the recent years in low- and middle-income countries. With high mortality and morbidity rates, it brings huge burden to the families. It lacks evidence regarding the application of intracranial pressure (ICP) monitoring in HICH. In the current study, the authors aimed to evaluate whether ICP monitoring could make any difference on the prognosis of HICH patients after minimally invasive surgery.
A retrospective review of 116 HICH patients admitted to the Second Affiliated Hospital of Zhejiang University School of Medicine, between 2014 and 2016, was performed. The effects of ICP monitoring on 6-month mortality and favorable outcomes were evaluated by univariate and logistic regression analysis.
ICP monitors were inserted into 50 patients. Patients with ICP monitoring had a significantly better outcome (<0.05). The average in-hospital duration in patients with ICP monitoring was shorter than that in the patients without ICP monitoring (16.68 days vs. 20.47 days, <0.05). Mortality rates between ICP monitoring and no ICP monitoring did not differ significantly (16.0% vs. 15.1%, =0.901). On univariate analysis, age, Glasgow Coma Scale (GCS) on admission and presence of ICP monitor were independent predictors of 6-month favorable outcomes.
ICP monitoring is associated with a better 6-month functional outcome compared with no ICP monitoring. Future study is still needed to confirm our results and elucidate which subgroup of HICH patients will benefit most from the minimally invasive surgical intervention and ICP monitoring.
近年来,低收入和中等收入国家高血压性脑出血(HICH)的发病率一直在上升。其高死亡率和高发病率给家庭带来了巨大负担。关于颅内压(ICP)监测在HICH中的应用缺乏证据。在本研究中,作者旨在评估ICP监测对微创术后HICH患者的预后是否有影响。
对2014年至2016年期间浙江大学医学院附属第二医院收治的116例HICH患者进行回顾性研究。通过单因素和逻辑回归分析评估ICP监测对6个月死亡率和良好预后的影响。
50例患者插入了ICP监测仪。进行ICP监测的患者预后明显更好(<0.05)。进行ICP监测的患者平均住院时间短于未进行ICP监测的患者(16.68天对20.47天,<0.05)。ICP监测组和未进行ICP监测组的死亡率无显著差异(16.0%对15.1%,=0.901)。单因素分析显示,年龄、入院时格拉斯哥昏迷量表(GCS)评分和是否使用ICP监测仪是6个月良好预后的独立预测因素。
与未进行ICP监测相比,ICP监测与更好的6个月功能预后相关。仍需进一步研究以证实我们的结果,并阐明哪些HICH患者亚组将从微创外科手术干预和ICP监测中获益最大。